Naresh Jain

Company: NJ Bio, Inc.

Job title: Chief Executive Officer

Seminars:

Accelerated Pathway from Antibody to ADC 10:30 am

The pathway from antibody to ADCs is complex, resource intensive, and time-consuming. There are numerous platform-based solutions including various classes of payloads, differing linker chemistries, and conjugation technologies to evaluate. All of these can seem like a minefield.  We will demonstrate how having high-quality material, expertise and the right technology can accelerate your ADC programs.Read more

day: day 2- am